Cardiovascular Systems
CSII
#6261
Rank
NZ$1.46 B
Marketcap
NZ$34.62
Share price
0.15%
Change (1 day)
25.09%
Change (1 year)
Categories

Revenue for Cardiovascular Systems (CSII)

Revenue in 2022 (TTM): NZ$0.38 Billion

According to Cardiovascular Systems's latest financial reports the company's current revenue (TTM ) is NZ$0.41 Billion. In 2021 the company made a revenue of NZ$0.36 Billion an increase over the revenue in the year 2020 that were of NZ$0.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cardiovascular Systems from 2004 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) NZ$0.38 B4.15%
2021 NZ$0.36 B16.43%
2020 NZ$0.31 B-19.35%
2019 NZ$0.39 B13.88%
2018 NZ$0.34 B18.05%
2017 NZ$0.29 B4.92%
2016 NZ$0.27 B5.39%
2015 NZ$0.26 B28.83%
2014 NZ$0.20 B43.47%
2013 NZ$0.14 B26.76%
2012 NZ$0.11 B9.63%
2011 NZ$0.10 B11%
2010 NZ$92.61 M10.09%
2009 NZ$84.12 M
2006 NZ$22.69 M3417.33%
2005 NZ$0.64 M-44.8%
2004 NZ$1.16 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AngioDynamics
ANGO
NZ$0.52 B 25.38%๐Ÿ‡บ๐Ÿ‡ธ USA
LeMaitre Vascular
LMAT
NZ$0.41 B 0.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$33.49 B 7,967.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
NZ$2.55 B 515.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$59.20 B 14,159.33%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
NZ$159.50 B 38,320.55%๐Ÿ‡บ๐Ÿ‡ธ USA